Browsing by Author "Nalcaci, Meliha"
Now showing items 1-3 of 3
-
Aberrant activation-induced cytidine deaminase gene expression links BCR/ABL1-negative classical myeloproliferative neoplasms
Dermenci, Hasan; Daglar Aday, Aynur; Akadam Teker, Aysegul Basak; Hancer, Veysel; Gelmez, Metin Yusuf; Nalcaci, Meliha; Yavuz, Akif Selim (TR- Dizin, 2022)Aim: Activation-induced cytidine deaminase (AID) has been associated with tumor initiation and development because of its ability to generate DNA damage and somatic mutations that cause genomic instability. This study ... -
Beta 2 glycoprotein ı valine247leucine polymorphism in patients with antiphospholipid syndrome
Tekeoglu, Senem; Hancer,Veysel Sabri; Esen, Bahar Artim; Nalcaci, Meliha; Inanc, Murat; Kucukkaya, Reyhan Diz (2022)"Aim: Beta 2 Glycoprotein I (β2-GP I) takes part in the pathogenesis of antiphospholipid syndrome (APS). Valine247Leucine (Val247Leu) gene polymorphism of β2-GP I might affect the binding/production of antiβ2-GP I ... -
The clinical significance of jak2v617f mutation for philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchic vein thrombosis
Hindilerden, Fehmi; Hindilerden, Ipek Yonal; Pinarbasi Simsek, Binnur; Hancer, Veysel Sabri; Kaymakoglu, Sabahattin; Kucukkaya, Reyhan Diz; Nalcaci, Meliha (Cig Media Group, Lp, 2019)Context: High prevalence of JAK2V617F mutation in splanchic vein thrombosis (SVT), including Budd-Chiari syndrome (BCS) and portal vein thrombosis (PVT) raised suspicion of an underlying Philadelphiaenegative chronic ...
